Q Bio Med Inc. QBIO

QBIO Quotes by TradingView

Quarterly Institutional Activity in QBIO

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding QBIO

View all
View all

Latest Institutional Activity in QBIO

Top Purchases

View All Buyers

Top Sells

Q3 2021
Kalos Management, Inc. Shares Held: 0 ($0)
10.6K Shares sold
Closed
Q3 2021
Ifp Advisors, Inc Shares Held: 0 ($0)
0 Shares sold
Closed
Q1 2021
Tradition Wealth Management, LLC Shares Held: 0 ($0)
30 Shares sold
Closed
Q1 2020
Bay Harbor Wealth Management, LLC Shares Held: 0 ($0)
142 Shares sold
Closed
Q3 2018
Trust CO Of Vermont Shares Held: 0 ($0)
900 Shares sold
Closed
View All Sellers

About QBIO

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.

QBIO Chart by TradingView
QBIO Fundamental Data by TradingView

Insider Transactions at QBIO

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
May 26 2022
Denis Corin Chief Executive Officer
BUY
Grant, award, or other acquisition
Direct
200,000 +7.04%
$4,000,000,000 $20000.0 P/Share
May 26 2022
William S Rosenstadt Chief Legal Officer
BUY
Grant, award, or other acquisition
Direct
250,000 +21.24%
$6,250,000,000 $25000.0 P/Share
Feb 01 2021
William S Rosenstadt Chief Legal Officer
BUY
Grant, award, or other acquisition
Direct
35,000 +5.08%
-
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on QBIO

Follow Q BioMed Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QBIO shares.

Notify only if
Any

Insider Trading

Get notified when an Q Bio Med Inc. insider buys or sells QBIO shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Q BioMed Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on QBIO